Vext Science, Inc.
VEXT
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 5.55% | 4.81% | -15.57% | -12.11% | -18.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.55% | 4.81% | -15.57% | -12.11% | -18.37% |
| Cost of Revenue | 89.32% | 147.01% | 63.49% | -28.28% | -47.22% |
| Gross Profit | -42.49% | -56.43% | -41.91% | 9.79% | 18.90% |
| SG&A Expenses | 0.25% | -60.66% | 0.71% | 118.27% | 88.31% |
| Depreciation & Amortization | 104.46% | 4.46% | 3.24% | 1,411.77% | 119.29% |
| Other Operating Expenses | -- | -- | -148.39% | -100.00% | -- |
| Total Operating Expenses | 53.79% | 42.36% | 26.71% | 10.30% | -19.42% |
| Operating Income | -233.00% | -75.53% | -80.70% | -65.74% | -12.75% |
| Income Before Tax | -572.74% | -126.62% | -128.65% | -94.78% | -59.29% |
| Income Tax Expenses | -659.03% | -453.61% | -177.36% | -1,442.62% | -64.63% |
| Earnings from Continuing Operations | -534.05% | -72.57% | -96.76% | 479.71% | -56.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -534.05% | -72.57% | -96.76% | 479.71% | -56.34% |
| EBIT | -233.00% | -75.53% | -80.70% | -65.74% | -12.75% |
| EBITDA | -79.64% | -43.35% | -54.27% | -26.96% | 21.32% |
| EPS Basic | -496.77% | -74.47% | -96.93% | 774.51% | -56.34% |
| Normalized Basic EPS | -532.14% | -124.51% | -108.28% | -77.78% | -62.67% |
| EPS Diluted | -510.00% | -64.00% | -96.93% | 1,293.75% | -57.75% |
| Normalized Diluted EPS | -528.57% | -124.51% | -108.28% | -77.78% | -60.00% |
| Average Basic Shares Outstanding | 8.32% | 8.37% | 8.23% | -33.74% | 1.14% |
| Average Diluted Shares Outstanding | 7.20% | 7.86% | 8.40% | -34.22% | -4.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
